TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is a specialty pharmaceuticals firm focused on women’s health solutions such as hormone therapy and contraceptive products, operating through the SIC categorization that encompasses pharmaceutical preparations and prescription endocrine agents, and the profile notes the company is traded as TXMD with CIK 25743. The company’s commercial portfolio centers on FDA-cleared transdermal patches, oral tablets, and related products intended for gynecologists, primary care physicians, and affiliated pharmacies serving middle-aged and menopausal patients, while its services include clinical education programs, patient assistance, and digital tools to support adherence. Given the regulated nature of prescription therapeutics, revenue depends on ongoing approvals, labeling changes, pricing pressure from insurers, supply-chain integrity, and the outcome of litigation or government investigations, and the company periodically updates investors as filings become available, although the latest filing details remain pending for public review. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025